Skip to main content
SpringerLink
Log in

The Abuse of Agents Used to Induce or Maintain General Anesthesia: Intravenous Hypnotics and the Halogenated Hydrocarbons

  • Chapter
Substance Abuse

Abstract

The agents used to induce or maintain general anesthesia have been shown time and time again, in multiple studies involving both humans and animals, to carry considerable abuse liability. These drugs are capable of producing pleasurable sensations and altering consciousness in a manner that some find pleasing. They have a demonstrated ability to reinforce drug-taking behaviors, can produce tolerance, and many are associated with the development of a withdrawal syndrome, yet these drugs are not very well controlled. Many are not scheduled by the DEA and those that are been given the least restrictive schedule IV status. These drugs are almost universally available in unsecured hospital supply rooms or anesthesia carts and few facilities keep specific usage records.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 109.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 139.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Eger EI. Characteristics of anesthetic agents used for induction and maintenance of general anesthesia. Am J Health Syst Pharmacol. 2004;61 Suppl 4:S3–10.

    CAS  Google Scholar 

  2. Short C, Bufalari A. Propofol anesthesia. Vet Clin North Am Small Anim Pract. 1999;29(3):747–78.

    Article  CAS  PubMed  Google Scholar 

  3. Wilson C, Canning P, Caravati EM. The abuse potential of propofol. Clin Toxicol (Phila). 2010;48(3):165–70.

    Article  CAS  Google Scholar 

  4. Karowski MD, Koltchine VV, Rick CE, et al. Propofol and other intravenous anesthetics have sites of action on the gamma-aminobutyric acid type A receptor distinct from that for isoflurane. Mol Pharmacol. 1998;53:530–8.

    Google Scholar 

  5. Kingston S, Mao L, Yang L, et al. Propofol inhibits phosphorylation of N-methyl-D-aspartate receptor NR1 subunits in neurons. Anesthesiology. 2006;104:763–9.

    Article  CAS  PubMed  Google Scholar 

  6. Brazzalotto I. Effects of propofol. Ann Fr Anesth Reanim. 1989;8:388.

    Article  CAS  PubMed  Google Scholar 

  7. Pain L, Gobaille S, Schleef C, et al. In vivo dopamine measurements in the nucleus accumbens after nonanesthetic and anesthetic doses of propofol in rats. Anesth Analg. 2002;95:191–6.

    Google Scholar 

  8. Keita H, Lecharny JB, Henzel D, et al. Is inhibition of dopamine uptake relevant to the hypnotic action of iv anesthetics? Br J Anaesth. 1996;77:254–6.

    Article  CAS  PubMed  Google Scholar 

  9. Xiong M, Zhang C. Molecular basis of propofol addiction. In: IARS annual meeting 2009, San Diego; 2005 (also identified in; Campton MG. Anesthesiology news. Molecular basis of propofol identified. Vol 35: 5; 1).

    Google Scholar 

  10. Frost EAM, Bryson EO. Propofol abuse. In: Bryson EO, Frost EAM, editors. Perioperative addiction. New York: Springer; 2011.

    Google Scholar 

  11. Merlo LJ, Goldberger BA, Kolodner D, et al. Fentanyl and propofol exposure in the operating room: sensitization hypotheses and further data. J Addict Dis. 2008;27(3):67–76.

    Article  PubMed  Google Scholar 

  12. Li KY, Xiao C, Xiong M, et al. Nanomolar propofol stimulates glutamate transmission to dopamine neurons: a possible mechanism of abuse potential? J Pharmacol Exp Ther. 2008;325(1):165–74.

    Article  CAS  PubMed  Google Scholar 

  13. Mc Auliffe PF, Gold MS, Bajpai L, et al. Second-hand exposure to aerosolized intravenous anesthetics propofol and fentanyl may cause sensitization and subsequent opiate addiction among anesthesiologists and surgeons. Med Hypotheses. 2006;68(5):874–82.

    Article  Google Scholar 

  14. Zacny JP, Lichtor JL, Thompson W, et al. Propofol at a subanesthetic dose may have abuse potential in healthy volunteers. Anesth Analg. 1993;77(3):544–52.

    Article  CAS  PubMed  Google Scholar 

  15. Roussin A, Monastrue JL, Lapeyre-Mestre M. Pharmacological and clinical evidences on the potential for abuse and dependence of propofol: a review of the literature. Fundam Clin Pharmacol. 2007;21(5):459–66.

    Article  CAS  PubMed  Google Scholar 

  16. Monroe T, Hamza H, Stocks G, Scimeca PD, Cowan R. The misuse and abuse of propofol. Subst Use Misuse. 2011;46:1199–205.

    Article  PubMed  Google Scholar 

  17. Soyka M, Schutz CG. Propfol dependency. Addiction. 1997;92(10):1369–70.

    Article  CAS  PubMed  Google Scholar 

  18. Bonnet U, Harkener J, Scherbaum N. A case report of propofol dependence in a physician. J Psychoactive Drugs. 2008;40(2):215–7.

    Article  PubMed  Google Scholar 

  19. Follette JW, Farley WJ. Anesthesiologist addicted to propofol. Anesthesiology. 1992;77:817–8.

    Article  CAS  PubMed  Google Scholar 

  20. Ward CF. Substance abuse, now and for some time to come. Anesthesiology. 1992;77:619–22.

    Article  CAS  PubMed  Google Scholar 

  21. Kranioti EF, Mavroforou A, Mylonakis P, Michalodimitrakis M. Lethal self-administration of propofol (Diprivan). A case report and review of the literature. Forensic Sci Int. 2007;167(1):56–8.

    Article  PubMed  Google Scholar 

  22. Klausz G, Rona K, Kristof I, et al. Evaluation of a fatal propofol intoxication due to self-administration. J Forensic Leg Med. 2009;16(5):287–9.

    Article  PubMed  Google Scholar 

  23. Iwerson-Bergmann S, Rosner P, Kohnau HC, et al. Death after excessive propofol abuse. Int J Legal Med. 2001;114(4–5):248–51.

    Article  Google Scholar 

  24. Fritz GA, Niemczyk WE. Propofol dependency in a lay person. Anesthesiology. 2002;96:505–6.

    Article  PubMed  Google Scholar 

  25. Strehler M, Preuss J, Wollersen H, et al. Lethal moxed intoxication with propofol in a medical layman. Arch Kriminol. 2008;217(5–6):153–60.

    Google Scholar 

  26. Wischmeyer PE, Johnson BR, Wilson JE. A survey of propofol abuse in academic anesthesia programs. Anesth Analg. 2007;105(4):1066–71.

    Article  CAS  PubMed  Google Scholar 

  27. Earley PH, Finver T. Addiction to propofol: a study of 22 treatment cases. J Addict Med. 2013;7(3):169–76.

    Article  CAS  PubMed  Google Scholar 

  28. Stelow EB, Johari VP, Smity SA, Crosson JT, Apple FS. Propofol associated rhabdomyolysis with cardiac involvement in adults: chemical and anatomic findings. Clin Chem. 2000;46:577–81.

    CAS  PubMed  Google Scholar 

  29. Vernooy K, Delhaas T, Cremer OL, et al. Electrocardiographic changes predicting sudden death in propofol-related infusion syndrome. Heart Rhythm. 2006;3:131–7.

    Article  PubMed Central  PubMed  Google Scholar 

  30. Riezzo I, Centini F, Neri M, et al. Brugada-like EKG pattern and myocardial effects in a chronic propofol abuser. Clin Toxicol. 2009;47:358–63.

    Article  Google Scholar 

  31. Robinson JD, Melman Y, Walsh EP. Cardiac conduction disturbances and ventricular tachycardia after prolonged propofol infusion in an infant. Pacing Clin Electrophysiol. 2008;31(8):1070–3.

    Article  PubMed  Google Scholar 

  32. Bebarta VS, Summera S. Predictor of mortality in suspected propofol infusion syndrome-Brugata electrocardiographic pattern. Crit Care Med. 2009;37(2):795–6.

    Article  PubMed  Google Scholar 

  33. Jorens PG, Van der Eynden GG. Propofol infusion syndrome with arrhythmia, myocardial fat accumulation and cardiac failure. Am J Cardiol. 2009;104(8):1160–2.

    Article  PubMed  Google Scholar 

  34. Riera AR, Lichida AH, Schapachnik E, et al. Propofol infusion syndrome and Brugada syndrome electrocardiographic phenocopy. Cardiol J. 2010;17(2):130–5.

    PubMed  Google Scholar 

  35. McMahon LR, Coop A, France CP, Winger G, Woolverton WL. Evaluation of the reinforcing and discriminative stimulus effects of 1,4-butanediol and gamma-butyrolactone in rhesus monkeys. Eur J Pharmacol. 2003;466:113–20.

    Article  CAS  PubMed  Google Scholar 

  36. Broadbear JH, Winger G, Woods JH. Self-administration of methohexital, midazolam and ethanol: effects on the pituitary-adrenal axis in rhesus monkeys. Psychopharmacology (Berl). 2005;178:83–91.

    Article  CAS  Google Scholar 

  37. Koffarnus MN, Hall A, Winger G. Individual differences in rhesus monkeys’ demand for drugs of abuse. Addict Biol. 2011;17:887–96.

    Article  PubMed  Google Scholar 

  38. Gaillard Y, Pepin G. Evidence of polydrug use using hair analysis: a fatal case involving heroin, cocaine, cannabis, chloroform, thiopental and ketamine. J Forensic Sci. 1998;43(2):435–8.

    CAS  PubMed  Google Scholar 

  39. Vanlersberghe C, Camu F. Etomidate and other non-barbiturates. Handb Exp Pharmacol. 2008;182(182):267–82.

    Article  CAS  PubMed  Google Scholar 

  40. Paramedic tampered with drugs. Spokane, WA:EMS Village; 11 October 2012.

    Google Scholar 

  41. Balster RL. Neural basis of inhalant abuse. Drug Alcohol Depend. 1998;51:207–14.

    Article  CAS  PubMed  Google Scholar 

  42. Maclver BM. Abused inhalants enhance GABA-mediated synaptic inhibition. Neuropsychopharmacology. 2009;34:2296–304.

    Article  Google Scholar 

  43. Lopreato GF, Phelan R, Borghese CM, Beckstead MJ, Mihic SJ. Inhaled drugs of abuse enhance serotonin-3 receptor function. Drug Alcohol Depend. 2003;70:11–5.

    Article  CAS  PubMed  Google Scholar 

  44. Bieda MC, Su H, MacIver MB. Anesthetics discriminate between tonic and phasic gamma-aminobutyric acid receptors on hippocampal CA1 neurons. Anesth Analg. 2009;108:484–90.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  45. Weintraub M, Groce P, Karno M. Chloroformism—a new case of a bad old habit. Calif Med. 1972;117(1):63–5.

    Google Scholar 

  46. Bowen SE, Balster RL. Desflurane, enflurane, isoflurane, and ether produce ethanol-like discriminative stimulus effects in mice. Pharmacol Biochem Behav. 1997;57:191–8.

    Article  CAS  PubMed  Google Scholar 

  47. Bowen SE, Balster RL. A direct comparison of inhalant effects on locomotor activity and scheduled-controlled behavior in mice. Exp Clin Psychopharmacol. 1998;6:235–47.

    Article  CAS  PubMed  Google Scholar 

  48. Walker DJ, Beckman NJ, Zacny JP. Reinforcing and subjective effects of the volatile anesthetic, sevoflurane. Drug Alcohol Depend. 2004;76:191–201.

    Article  CAS  PubMed  Google Scholar 

  49. Smith RA, Winter PM, Smith M, Eger EI. Tolerance to and dependence on inhalational anesthetics. Anesthesiology. 1979;50:505–9.

    Article  CAS  PubMed  Google Scholar 

  50. Levine B, Cox D, Jufer-Phipps RA, Li L, Jacobs A, Fowler D. A fatality from sevoflurane abuse. J Anal Toxicol. 2007;31:534–6.

    Article  CAS  PubMed  Google Scholar 

  51. Caltrell FL. A fatal case of sevoflurane abuse. Clin Toxicol. 2008;46:918–9.

    Article  Google Scholar 

  52. Pavlic M, Haidekker A, Grubwieser P, Rabl W. Fatal accident caused by isoflurane abuse. Int J Legal Med. 2002;116:357–60.

    Article  CAS  PubMed  Google Scholar 

  53. Dooper MM, Beerens J, Brenninkmeijer VJ, Gerlag PG. Fatal intoxication after ingestion of isoflurane. Neth J Med. 1988;33:74–7.

    CAS  PubMed  Google Scholar 

  54. Kuhlman JJ, Magluilo J, Levine B, Smith ML. Two deaths involving isoflurane abuse. J Forensic Sci. 1993;38:968–71.

    PubMed  Google Scholar 

  55. Krajcovic J, Novomesky F, Stuller F, Straka L, Mokry J. An unusual case of anesthetic abuse by a full-face gas mask. Am J Forensic Med Pathol. 2012;33:256–8.

    Article  PubMed  Google Scholar 

  56. Kaplan HG, Bakken J, Quadracci L, et al. Hepatitis caused by halothane sniffing. Ann Intern Med. 1979;90:797–8.

    Article  CAS  PubMed  Google Scholar 

  57. Madea B, Musshoff F. Homicidal poisioning with halothane. Int J Legal Med. 1999;113:47–9.

    Article  CAS  PubMed  Google Scholar 

  58. Spencer AE, Green NM. Suicide by ingestion of halothane. JAMA. 1968;168:702–3.

    Article  Google Scholar 

  59. Spencer JD, Raasch FO, Trefny FA. Halothane abuse in hospital personnel. JAMA. 1976;235(10):1034–5.

    Article  CAS  PubMed  Google Scholar 

  60. Lingenfelter RW. Fatal misuse of enflurane. Anesthesiology. 1981;50:603.

    Article  Google Scholar 

  61. Jacob B, Heller C, Daldrup T, Burrig KF, Barz J, Bonte W. Fatal accidental enflurane intoxication. J Forensic Sci. 1989;34(6):1408–12.

    CAS  PubMed  Google Scholar 

  62. Walker FB, Morano RA. Fatal recreational inhalation of enflurane. J Forensic Sci. 1990;35(1):197–8.

    CAS  PubMed  Google Scholar 

  63. Musshoff F, Junker H, Madea B. An unusual case of driving under the influence of enflurane. Forensic Sci Int. 2002;128:187–9.

    Article  CAS  PubMed  Google Scholar 

  64. Bryson EO, Frost EAM. Marijuana, nitrous oxide and other inhalants. In: Bryson EO, Frost EAM, editors. Perioperative addiction. New York: Springer; 2011.

    Google Scholar 

  65. Kurtzman TL, Otsuka KN, Wahl RA. Inhalant abuse by adolescents. J Adolesc Health. 2001;28:170–80.

    Article  CAS  PubMed  Google Scholar 

  66. Sicinski M, Kadam U. Monitoring of the anesthetic volatile agent may be impaired in hydrocarbon abusers. Anesthesia. 2002;57:510–1.

    Article  CAS  Google Scholar 

  67. Broussard LA. The role of the laboratory in detecting inhalant abuse. Clin Lab Sci. 2000;13:205–9.

    CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Anesthesiology and Psychiatry, Icahn School of Medicine at Mount Sinai, New York, NY, USA

    Ethan O. Bryson M.D.

Authors
  1. Ethan O. Bryson M.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Ethan O. Bryson M.D. .

Editor information

Editors and Affiliations

  1. Louisiana State University Health Sciences Center, Louisiana State University Interim Hospital, and Ochsner Kenner Hospital, Departments of Anesthesiology and Pharmacology, New Orleans, Louisiana, USA

    Alan David Kaye

  2. Department of Anesthesiology, Yale University School of Medicine and Yale-New Haven Hospital, New Haven, Connecticut, USA

    Nalini Vadivelu

  3. Department of Anesthesiology, Perioperative and Pain Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA

    Richard D. Urman

Rights and permissions

Reprints and permissions

Copyright information

© 2015 Springer Science+Business Media New York

About this chapter

Cite this chapter

Bryson, E.O. (2015). The Abuse of Agents Used to Induce or Maintain General Anesthesia: Intravenous Hypnotics and the Halogenated Hydrocarbons. In: Kaye, A., Vadivelu, N., Urman, R. (eds) Substance Abuse. Springer, New York, NY. https://doi.org/10.1007/978-1-4939-1951-2_10

Download citation

  • DOI: https://doi.org/10.1007/978-1-4939-1951-2_10

  • Publisher Name: Springer, New York, NY

  • Print ISBN: 978-1-4939-1950-5

  • Online ISBN: 978-1-4939-1951-2

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation